| 000 | 00927 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250518040306.0 | ||
| 008 | ####s 0 0 eng d | ||
| 022 | _a1475-2867 | ||
| 024 | 7 |
_a10.1186/s12935-019-0836-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSong, Yong-An | |
| 245 | 0 | 0 |
_aApatinib preferentially inhibits PC9 gefitinib-resistant cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway. _h[electronic resource] |
| 260 |
_bCancer cell international _c2019 |
||
| 300 |
_a117 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 700 | 1 | _aMa, Ting | |
| 700 | 1 | _aZhang, Xue-Yan | |
| 700 | 1 | _aCheng, Xiang-Song | |
| 700 | 1 | _aOlajuyin, Ayobami-Matthew | |
| 700 | 1 | _aSun, Zhi-Fu | |
| 700 | 1 | _aZhang, Xiao-Ju | |
| 773 | 0 |
_tCancer cell international _gvol. 19 _gp. 117 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12935-019-0836-8 _zAvailable from publisher's website |
| 999 |
_c29675193 _d29675193 |
||